300 related articles for article (PubMed ID: 19179438)
1. Retinoic acid reduces glucocorticoid sensitivity in C2C12 myotubes by decreasing 11beta-hydroxysteroid dehydrogenase type 1 and glucocorticoid receptor activities.
Aubry EM; Odermatt A
Endocrinology; 2009 Jun; 150(6):2700-8. PubMed ID: 19179438
[TBL] [Abstract][Full Text] [Related]
2. Cortisone induces insulin resistance in C2C12 myotubes through activation of 11beta-hydroxysteroid dehydrogenase 1 and autocrinal regulation.
Park SY; Bae JH; Cho YS
Cell Biochem Funct; 2014 Apr; 32(3):249-57. PubMed ID: 24122936
[TBL] [Abstract][Full Text] [Related]
3. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of 11beta-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes.
Abdallah BM; Beck-Nielsen H; Gaster M
Eur J Clin Invest; 2005 Oct; 35(10):627-34. PubMed ID: 16178882
[TBL] [Abstract][Full Text] [Related]
5. Cell-based assay for screening 11beta-hydroxysteroid dehydrogenase 1 inhibitors.
Cho YS; Kim CH; Cheon HG
Anal Biochem; 2009 Sep; 392(2):110-6. PubMed ID: 19497289
[TBL] [Abstract][Full Text] [Related]
6. Glucocorticoids and 11β-HSD1 are major regulators of intramyocellular protein metabolism.
Morgan SA; Hassan-Smith ZK; Doig CL; Sherlock M; Stewart PM; Lavery GG
J Endocrinol; 2016 Jun; 229(3):277-86. PubMed ID: 27048233
[TBL] [Abstract][Full Text] [Related]
7. 7-oxysterols modulate glucocorticoid activity in adipocytes through competition for 11beta-hydroxysteroid dehydrogenase type.
Wamil M; Andrew R; Chapman KE; Street J; Morton NM; Seckl JR
Endocrinology; 2008 Dec; 149(12):5909-18. PubMed ID: 18755798
[TBL] [Abstract][Full Text] [Related]
8. 11beta-hydroxysteroid dehydrogenase type 1 regulates glucocorticoid-induced insulin resistance in skeletal muscle.
Morgan SA; Sherlock M; Gathercole LL; Lavery GG; Lenaghan C; Bujalska IJ; Laber D; Yu A; Convey G; Mayers R; Hegyi K; Sethi JK; Stewart PM; Smith DM; Tomlinson JW
Diabetes; 2009 Nov; 58(11):2506-15. PubMed ID: 19675138
[TBL] [Abstract][Full Text] [Related]
9. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice.
Liu Y; Nakagawa Y; Wang Y; Sakurai R; Tripathi PV; Lutfy K; Friedman TC
Diabetes; 2005 Jan; 54(1):32-40. PubMed ID: 15616008
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of glucocorticoid-induced 11beta-hydroxysteroid dehydrogenase type 1 expression by proinflammatory cytokines in cultured human amnion fibroblasts.
Sun K; Myatt L
Endocrinology; 2003 Dec; 144(12):5568-77. PubMed ID: 12960005
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the Nrf2-dependent antioxidant response by glucocorticoids and 11β-HSD1-mediated glucocorticoid activation in hepatic cells.
Kratschmar DV; Calabrese D; Walsh J; Lister A; Birk J; Appenzeller-Herzog C; Moulin P; Goldring CE; Odermatt A
PLoS One; 2012; 7(5):e36774. PubMed ID: 22606287
[TBL] [Abstract][Full Text] [Related]
12. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
Masuzaki H; Flier JS
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
[TBL] [Abstract][Full Text] [Related]
13. Effects of a high-salt diet on adipocyte glucocorticoid receptor and 11-beta hydroxysteroid dehydrogenase 1 in salt-sensitive hypertensive rats.
Usukura M; Zhu A; Yoneda T; Karashima S; Yagi K; Yamagishi M; Takeda Y
Steroids; 2009 Nov; 74(12):978-82. PubMed ID: 19646461
[TBL] [Abstract][Full Text] [Related]
14. 11beta-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP(+) and is stimulated by extracellular glucose.
Dzyakanchuk AA; Balázs Z; Nashev LG; Amrein KE; Odermatt A
Mol Cell Endocrinol; 2009 Mar; 301(1-2):137-41. PubMed ID: 18778749
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of 11beta-hydroxysteroid dehydrogenase types 1 and 2 mRNA and glucocorticoid receptor protein during mouse embryonic development.
Thompson A; Han VK; Yang K
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):367-75. PubMed ID: 15145446
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
Wang M
Handb Exp Pharmacol; 2011; (203):127-46. PubMed ID: 21484570
[TBL] [Abstract][Full Text] [Related]
17. Cellular and genetic models of H6PDH and 11β-HSD1 function in skeletal muscle.
Zielinska AE; Fletcher RS; Sherlock M; Doig CL; Lavery GG
Cell Biochem Funct; 2017 Jul; 35(5):269-277. PubMed ID: 28749080
[TBL] [Abstract][Full Text] [Related]
18. Regulation of lipid metabolism by glucocorticoids and 11β-HSD1 in skeletal muscle.
Morgan SA; Gathercole LL; Simonet C; Hassan-Smith ZK; Bujalska I; Guest P; Abrahams L; Smith DM; Stewart PM; Lavery GG; Tomlinson JW
Endocrinology; 2013 Jul; 154(7):2374-84. PubMed ID: 23633532
[TBL] [Abstract][Full Text] [Related]
19. Decreased 11β-hydroxysteroid dehydrogenase 1 in lungs of steroid receptor coactivator (Src)-1/-2 double-deficient fetal mice is caused by impaired glucocorticoid and cytokine signaling.
Chen J; Mishra R; Yu Y; McDonald JG; Eckert KM; Gao L; Mendelson CR
FASEB J; 2020 Dec; 34(12):16243-16261. PubMed ID: 33070362
[TBL] [Abstract][Full Text] [Related]
20. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.
Apostolova G; Schweizer RA; Balazs Z; Kostadinova RM; Odermatt A
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E957-64. PubMed ID: 15613680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
